Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Taxus Companies Clash With Conor Over European Paclitaxel Patent

This article was originally published in The Pink Sheet Daily

Executive Summary

Boston Scientific's suit against Conor Medsystems over paclitaxel will draw from a $75 mil. legal reserve established by the Taxus manufacturer in 2004. Angiotech is joining Boston Scientific in suing Conor over the CoStar drug-eluting stent, seeking to halt use of clinical trial data, potential sales.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS061691

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel